Multimodality Risk Adapted Tx Including Induction Chemo for SCCHN Amenable to Transoral Surgery
UNC Lineberger Comprehensive Cancer Center
UNC Lineberger Comprehensive Cancer Center
Case Comprehensive Cancer Center
Vanderbilt-Ingram Cancer Center
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
M.D. Anderson Cancer Center
Seoul National University Bundang Hospital
Salzburger Landeskliniken
UNC Lineberger Comprehensive Cancer Center
Abramson Cancer Center at Penn Medicine
University of Maryland, Baltimore
Washington University School of Medicine
University of Chicago
NRG Oncology
Massachusetts General Hospital
University of Colorado, Denver
H. Lee Moffitt Cancer Center and Research Institute
Wake Forest University Health Sciences
UNC Lineberger Comprehensive Cancer Center
Royal Marsden NHS Foundation Trust
University of Chicago
University of Pittsburgh
H. Lee Moffitt Cancer Center and Research Institute
Mashhad University of Medical Sciences
Centre Henri Becquerel
Memorial Sloan Kettering Cancer Center
Institut de Cancérologie de Lorraine
Mayo Clinic
H. Lee Moffitt Cancer Center and Research Institute
Cliniques universitaires Saint-Luc- Université Catholique de Louvain
H. Lee Moffitt Cancer Center and Research Institute
Memorial Sloan Kettering Cancer Center
University of Chicago
New York University
M.D. Anderson Cancer Center
Radboud University Medical Center
UNICANCER
Universitair Ziekenhuis Brussel
Centre Hospitalier Universitaire de Nīmes
University of Pittsburgh
University of Kentucky
M.D. Anderson Cancer Center
University of Arkansas
Sanford Health
Insel Gruppe AG, University Hospital Bern
Vanderbilt-Ingram Cancer Center
Bruce Robinson, MD
NYU Langone Health
Karolinska University Hospital
M.D. Anderson Cancer Center
Memorial Sloan Kettering Cancer Center